Skip Navigation

Banner MD Anderson Cancer Center

Location

Banner MD Anderson Cancer Center
Stem Cell Transplant and Cellular Therapy Prg

2946 E Banner Gateway Drive
3 South
Gilbert, AZ 85234
Direct phone: (480) 256-6444

Total transplants by cell source

From January 1, 2019 to December 31st, 2020
  • Marrow: 3
  • PBSC: 93
  • Cord Blood: 3
  • Autologous (PBSC or Marrow): 87
Performs adult transplants

Overview

Banner MD Anderson Cancer Stem Cell Transplant and Cellular Therapy Program is on the campus of Banner Gateway Medical Center. The program began in 2013 with autologous stem cell transplants, moving to related donor allogeneic stem cell transplants in 2014. In 2017, became accredited with the Foundation for Accreditation of Cellular Therapy for autologous (reaccreditation), allogeneic and effector cell therapy. The team consists of experienced physicians, advanced practice providers, nurse coordinators, nursing staff, social workers, psychologists, cryotherapy lab, and support staff to provide compassionate care to the patient, family and their support systems. The program provides services for matched, mismatched related and unrelated donors, cord blood, and haplo-identical transplants. This center has been performing allogeneic transplants since 2014 and has been an NMDP/Be The Match transplant center since October 2016.

This center has been performing allogeneic transplants since 2014 and has been an NMDP/Be The Match transplant center since October 2016.

Attending physicians

Adult - Aileen Go, Murali Kodali, Rajneesh Nath, Matthew Ulrickson

Transplants performed

Marrow/PBSC and single cord

Cord blood transplants performed on

Adult only

Other programs and services

Clinical trials as well as commercial availability for immune effector cell therapy.

About the center

Overview

Banner MD Anderson Cancer Stem Cell Transplant and Cellular Therapy Program is on the campus of Banner Gateway Medical Center. The program began in 2013 with autologous stem cell transplants, moving to related donor allogeneic stem cell transplants in 2014. In 2017, became accredited with the Foundation for Accreditation of Cellular Therapy for autologous (reaccreditation), allogeneic and effector cell therapy. The team consists of experienced physicians, advanced practice providers, nurse coordinators, nursing staff, social workers, psychologists, cryotherapy lab, and support staff to provide compassionate care to the patient, family and their support systems. The program provides services for matched, mismatched related and unrelated donors, cord blood, and haplo-identical transplants. This center has been performing allogeneic transplants since 2014 and has been an NMDP/Be The Match transplant center since October 2016.

This center has been performing allogeneic transplants since 2014 and has been an NMDP/Be The Match transplant center since October 2016.

Attending physicians

Adult - Aileen Go, Murali Kodali, Rajneesh Nath, Matthew Ulrickson

Transplants performed

Marrow/PBSC and single cord

Cord blood transplants performed on

Adult only

Other programs and services

Clinical trials as well as commercial availability for immune effector cell therapy.

Overall center survival


Patient survival information for this center

This center's actual 1-year survival results are similar to the expected rate for this center.

The survival information we have for this center includes ONLY:

  1. Patients who had their FIRST ALLOGENEIC transplant (cells from a related or unrelated donor/cord blood) during 2017, 2018, 2019, and
  2. Who had their transplant at a U.S. transplant center, and
  3. Who had follow-up information provided by the transplant center for analysis

For this center, we have survival information for 110 patients.

The actual 1-year survival of these patients is 69.9%.

Compared to similar patients transplanted at all centers in the U.S., we expect that the 1-year survival for patients at this center to be in a range between 60.0% and 76.4%.

For help with understanding these statistics, please see Understanding Transplant Outcomes.

For overall survival for all patients transplanted with a specific disease, please see U.S. Patient Survival report at bloodcell.transplant.hrsa.gov.

Total transplants

Total transplants


186

Transplants reported (From January 1, 2019 to December 31st, 2020 as reported by the centers)

Marrow PBSC Cord blood Total
Allogeneic
Related donor 2 38 0 40
Unrelated donor 1 55 3 59
Total allogeneic 3 93 3 99
Autologous
Both marrow & PBSC
87
-- 87
Total combined
183 3 186

Transplants by disease

All diseases

Number of transplants by age reported from January 1, 2019 to December 31st, 2020 (includes marrow, PBSC and cord blood)

0-18 19-44 45-64 65+ Total
Related 0 19 16 5 40
Unrelated 0 15 13 31 59
Autologous 0 13 33 41 87
Total 0 47 62 77 186

Treatments may be similar for diseases within a group. It might be helpful to look at centers that have done transplants for a specific disease and centers that have done transplants for any corresponding broad disease categories.

Centers are not required to report autologous transplants so the numbers might be incomplete.

More information about transplants for this disease can be found:

Additional information

Transplant center resources

Transplant center coordinator:
September Mitchell
(480) 256-4249
Email: september.mitchell@bannerhealth.com

If you have questions about costs and financial services at this center, please call the transplant center's direct phone number.

Be The Match patient navigators

Patient navigators can answer your questions about choosing a transplant center and provide support and education to help you throughout your transplant journey.

Inside the United States: 1 (888) 999-6743

Outside the United States: 1 (763) 406-3410.
(Long distance or international charges may apply.)

Email: patientinfo@nmdp.org

Survivorship program

Loading survivorship program information...